In this study, we discovered that the down-regulation of APLP2 in pancreatic cancer cells caused major changes in the actin cytoskeleton in vitro (Figure 4) and in the composition of covalently linked actin-positive complexes in pancreatic tumors in vivo (Figure 6, upper right panel). This evidence concerns the gene APLP2 and pancreatic neoplasm.